Delivery Order SPE2DB20D1100-SPE2DB25FC0K9
Award Date 4/30/25
Potential Completion Date 5/21/25
Potential Value $56K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $55,852.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on May 9, 2025, with an ultimate completion date of June 2, 2025. GAMUNEX-C is an intravenous immunoglobulin therapy used to treat immunodeficiency conditions and autoimmune disorders. This non-set-aside competitive award represents a single delivery order fulfillment under AmerisourceBergen's broader contract vehicle with the DLA. The work will be...
- The Defense Logistics Agency awarded a $17,702.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on September 18, 2025, with an ultimate completion date of October 9, 2025. GAMUNEX-C is an intravenous immunoglobulin used to treat immunodeficiency disorders and autoimmune conditions. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a $13,963.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 mL vials on June 30, 2025, with an ultimate completion date of July 22, 2025. GAMUNEX-C is an intravenous immunoglobulin (IVIG) product used to treat various immunodeficiency conditions and autoimmune disorders. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $55,852.80 delivery order on August 18, 2025, for GAMUNEX-C 40 gram/400 ml vials with a completion date of September 9, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin (IVIG) therapy used to treat immune deficiencies and certain autoimmune and inflammatory...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,468.56 for GAMUNEX-C 1 gram/10 mL vials on August 26, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin used to treat primary immunodeficiency and other...
- The Defense Logistics Agency awarded a delivery order valued at $60,799.14 to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on August 22, 2025, with completion scheduled for September 15, 2025. GAMUNEX-C is an intravenous immunoglobulin (IVIG) product used to treat primary immunodeficiency and other immune-related conditions. This competitively awarded, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $4,555.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of GAMUNEX-C 5 gram/50 mL vials. This is a non-set-aside competitive award with an ultimate completion date of September 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immunoglobulin therapy used to treat various immune deficiencies and autoimmune conditions, representing the type...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 40 gram/400 milliliter vials on April 21, 2025, with a completion date of May 12, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an intravenous immune globulin (IVIG) product used to treat immunodeficiency and autoimmune disorders, representing a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of GAMUNEX-C 10 gram/100 mL vials totaling $18,314.10 with a completion date of September 26, 2025. This is a firm fixed-price delivery order issued under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $41,178.10 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by August 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. GAMUNEX-C is an immune globulin intravenous (human) product used in treating immune deficiency disorders and is a critical pharmaceutical...